2025-07-02 REL PDBe INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY EXPERIMENTAL_SUMMARY em_admin em_software _em_admin.last_update _em_software.name DATABASE_REFERENCES citation citation_author _citation.journal_volume _citation.page_first _citation.page_last _citation_author.identifier_ORCID DATABASE_REFERENCES citation_author _citation_author.identifier_ORCID STRUCTURE_SUMMARY database_2 entity entity_name_com entity_src_gen _database_2.pdbx_DOI _database_2.pdbx_database_accession _entity.pdbx_description _entity_src_gen.gene_src_common_name STRUCTURE_SUMMARY chem_comp_atom chem_comp_bond em_admin pdbx_entry_details pdbx_modification_feature _em_admin.last_update _pdbx_entry_details.has_protein_modification DATA_COLLECTION em_admin em_software _em_admin.last_update _em_software.name PDBe PDBe 2020-06-14 2020-07-29 2020-07-29 2025-07-02 Medical Research Council (MRC, United Kingdom) MR/N00065X/1 United Kingdom Wellcome Trust 101122/Z/13/Z United Kingdom CAMS Innovation Fund for Medical Sciences (CIFMS) 2018-I2M-2-002 China Association of three complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab Duyvesteyn HME Zhou D Zhao Y Fry EE Ren J Stuart DI EY6a, RBD, Spike glycoprotein, SARS-CoV-2, human neutralizing antibody, VIRAL PROTEIN Zhou D Duyvesteyn HME Chen CP Huang CG Chen TH Shih SR Lin YC Cheng CY Cheng SH Huang YC Lin TY Ma C Huo J Carrique L Malinauskas T Ruza RR Shah PNM Tan TK Rijal P Donat RF Godwin K Buttigieg KR Tree JA Radecke J Paterson NG Supasa P Mongkolsapaya J Screaton GR Carroll MW Gilbert-Jaramillo J Knight ML James W Owens RJ Naismith JH Townsend AR Fry EE Zhao Y Ren J Stuart DI Huang KA Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat.Struct.Mol.Biol. US 27 950 958 2020 32737466 doi:10.1038/s41594-020-0480-y 1545-9985 6zdg FULLOVERLAP Complex of SARS-CoV-2 Spike ectodomain with EY6A Fab Complex of SARS-CoV-2 Spike ectodomain with EY6A Fab 0 2 3
SDS PAGE analysis shows that the Spike polypeptide remains largely uncleaved, while the density only shows S1 subunit
Severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 neutralizing antibody EY6A Fab 1 2 3 human Spike protein S1 Severe acute respiratory syndrome coronavirus 2 0.021776381 3 Homo sapiens LEVO TNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAP GQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPL QSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCG P0DTC2 EY6A heavy chain Homo sapiens 0.024346273 3 Cricetulus griseus LEVO EVQLVESGGGVVQPGRSLRLSCAASAFTFSSYDMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLY LQMNSLRAEDTAVYYCAKDGGKLWVYYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTV SWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDK EY6A light chain Homo sapiens 0.023315855 3 Cricetulus griseus LEVO DIQMTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQP EDFATYYCQQSYSTLALTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNS QESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC 2-acetamido-2-deoxy-beta-D-glucopyranose 0.000221208 3 NAG singleParticle particle 8.0 ETHANE-PROPANE FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 GATAN K3 (6k x 4k) 42.2 1 Gctf PHASE FLIPPING AND AMPLITUDE CORRECTION Ab initio model generated in cryosparc. C3 4.7 FSC 0.143 CUT-OFF cryoSPARC 41372 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD cryoSPARC emd_11173.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 560 560 560 0 0 0 560 560 560 464.8 464.8 464.8 90.0 90.0 90.0 X Y Z -1.2306092 1.7205038 0.0013574851 0.021830682 0.83 0.83 0.83 0.25 AUTHOR